Cargando…

SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy

Lombardy is the Italian region most affected by COVID-19. We tested the presence of plasma anti-SARS-CoV-2 IgG antibodies in 3985 employees across 7 healthcare facilities in areas of Lombardy with different exposure to the SARS-CoV-2 epidemic. Subjects filled a questionnaire to self-report on COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandri, Maria Teresa, Azzolini, Elena, Torri, Valter, Carloni, Sara, Pozzi, Chiara, Salvatici, Michela, Tedeschi, Michele, Castoldi, Massimo, Mantovani, Alberto, Rescigno, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192543/
https://www.ncbi.nlm.nih.gov/pubmed/34112899
http://dx.doi.org/10.1038/s41598-021-91773-4
_version_ 1783706069442232320
author Sandri, Maria Teresa
Azzolini, Elena
Torri, Valter
Carloni, Sara
Pozzi, Chiara
Salvatici, Michela
Tedeschi, Michele
Castoldi, Massimo
Mantovani, Alberto
Rescigno, Maria
author_facet Sandri, Maria Teresa
Azzolini, Elena
Torri, Valter
Carloni, Sara
Pozzi, Chiara
Salvatici, Michela
Tedeschi, Michele
Castoldi, Massimo
Mantovani, Alberto
Rescigno, Maria
author_sort Sandri, Maria Teresa
collection PubMed
description Lombardy is the Italian region most affected by COVID-19. We tested the presence of plasma anti-SARS-CoV-2 IgG antibodies in 3985 employees across 7 healthcare facilities in areas of Lombardy with different exposure to the SARS-CoV-2 epidemic. Subjects filled a questionnaire to self-report on COVID-19 symptoms, comorbidities, smoking, regular or remote working, and the exposure to COVID-infected individuals. We show that the number of individuals exposed to the virus depended on the geographical location of the facility, ranging between 3 and 43%, consistent with the spatial variation of COVID-19 incidence in Lombardy, and correlated with family interactions. We observed a higher prevalence of females than males positive for IgG, however the level of antibodies was similar, suggesting a comparable magnitude of the anti-spike antibody response. IgG positivity among smokers was lower (7.4% vs 13.5%) although without difference in IgG plasma levels. We observed 11.9% of IgG positive asymptomatic individuals and another 23.1% with one or two symptoms. Interestingly, among the IgG positive population, 81.2% of subjects with anosmia/dysgeusia and fever were SARS-CoV-2 infected, indicating that these symptoms are strongly associated to COVID-19. In conclusion, the frequency of IgG positivity and SARS-CoV-2 infection is dependent on the geographical exposure to the virus and primarily to family rather than hospital exposure.
format Online
Article
Text
id pubmed-8192543
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81925432021-06-14 SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy Sandri, Maria Teresa Azzolini, Elena Torri, Valter Carloni, Sara Pozzi, Chiara Salvatici, Michela Tedeschi, Michele Castoldi, Massimo Mantovani, Alberto Rescigno, Maria Sci Rep Article Lombardy is the Italian region most affected by COVID-19. We tested the presence of plasma anti-SARS-CoV-2 IgG antibodies in 3985 employees across 7 healthcare facilities in areas of Lombardy with different exposure to the SARS-CoV-2 epidemic. Subjects filled a questionnaire to self-report on COVID-19 symptoms, comorbidities, smoking, regular or remote working, and the exposure to COVID-infected individuals. We show that the number of individuals exposed to the virus depended on the geographical location of the facility, ranging between 3 and 43%, consistent with the spatial variation of COVID-19 incidence in Lombardy, and correlated with family interactions. We observed a higher prevalence of females than males positive for IgG, however the level of antibodies was similar, suggesting a comparable magnitude of the anti-spike antibody response. IgG positivity among smokers was lower (7.4% vs 13.5%) although without difference in IgG plasma levels. We observed 11.9% of IgG positive asymptomatic individuals and another 23.1% with one or two symptoms. Interestingly, among the IgG positive population, 81.2% of subjects with anosmia/dysgeusia and fever were SARS-CoV-2 infected, indicating that these symptoms are strongly associated to COVID-19. In conclusion, the frequency of IgG positivity and SARS-CoV-2 infection is dependent on the geographical exposure to the virus and primarily to family rather than hospital exposure. Nature Publishing Group UK 2021-06-10 /pmc/articles/PMC8192543/ /pubmed/34112899 http://dx.doi.org/10.1038/s41598-021-91773-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Sandri, Maria Teresa
Azzolini, Elena
Torri, Valter
Carloni, Sara
Pozzi, Chiara
Salvatici, Michela
Tedeschi, Michele
Castoldi, Massimo
Mantovani, Alberto
Rescigno, Maria
SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy
title SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy
title_full SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy
title_fullStr SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy
title_full_unstemmed SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy
title_short SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy
title_sort sars-cov-2 serology in 4000 health care and administrative staff across seven sites in lombardy, italy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192543/
https://www.ncbi.nlm.nih.gov/pubmed/34112899
http://dx.doi.org/10.1038/s41598-021-91773-4
work_keys_str_mv AT sandrimariateresa sarscov2serologyin4000healthcareandadministrativestaffacrosssevensitesinlombardyitaly
AT azzolinielena sarscov2serologyin4000healthcareandadministrativestaffacrosssevensitesinlombardyitaly
AT torrivalter sarscov2serologyin4000healthcareandadministrativestaffacrosssevensitesinlombardyitaly
AT carlonisara sarscov2serologyin4000healthcareandadministrativestaffacrosssevensitesinlombardyitaly
AT pozzichiara sarscov2serologyin4000healthcareandadministrativestaffacrosssevensitesinlombardyitaly
AT salvaticimichela sarscov2serologyin4000healthcareandadministrativestaffacrosssevensitesinlombardyitaly
AT tedeschimichele sarscov2serologyin4000healthcareandadministrativestaffacrosssevensitesinlombardyitaly
AT castoldimassimo sarscov2serologyin4000healthcareandadministrativestaffacrosssevensitesinlombardyitaly
AT mantovanialberto sarscov2serologyin4000healthcareandadministrativestaffacrosssevensitesinlombardyitaly
AT rescignomaria sarscov2serologyin4000healthcareandadministrativestaffacrosssevensitesinlombardyitaly